Seer Inc (SEER)
2.345
+0.03
(+1.16%)
USD |
NASDAQ |
Nov 14, 10:32
Seer Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
--
Maximum
Jun 2021
--
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Organogenesis Holdings Inc | 0.2409 |
| Poseida Therapeutics Inc | 0.9668 |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.4322 |
| IGC Pharma Inc | 0.0173 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 383.42M |
| Total Liabilities (Quarterly) | 38.70M |
| Shareholders Equity (Quarterly) | 344.73M |
| Current Ratio | 18.36 |